Artificial intelligence predicts immune and inflammatory gene signatures directly from hepatocellular carcinoma histology

Hepatocellular carcinoma

(2021) Josep M. Llovet et al.   Nature Reviews Disease Primers

Data-efficient and weakly supervised computational pathology on whole-slide images

(2021) Ming Y. Lu et al.   Nature Biomedical Engineering

AI-based pathology predicts origins for cancers of unknown primary

(2021) Ming Y. Lu et al.   NATURE

Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020)

(2021) Philipp K. Haber et al.   GASTROENTEROLOGY

Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma.

(2021) Philipp K. Haber et al.   JOURNAL OF CLINICAL ONCOLOGY

CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma

(2020) Qiu-Zhong Pan et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Predicting survival after hepatocellular carcinoma resection using deep‐learning on histological slides

(2020) Charlie Saillard et al.   HEPATOLOGY

IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation

(2020) Stephen P Hack et al.   Future Oncology

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

(2020) Richard S. Finn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical-grade Detection of Microsatellite Instability in Colorectal Tumors by Deep Learning

(2020) Amelie Echle et al.   GASTROENTEROLOGY

Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma

(2020) Bruno Sangro et al.   JOURNAL OF HEPATOLOGY

Development of AI-based pathology biomarkers in gastrointestinal and liver cancer

(2020) Jakob N. Kather et al.   Nature Reviews Gastroenterology & Hepatology

Artificial intelligence-based pathology for gastrointestinal and hepatobiliary cancers

(2020) Julien Calderaro et al.   GUT

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial

(2019) Andrew X Zhu et al.   LANCET ONCOLOGY

Clinical impact of genomic diversity from early to advanced hepatocellular carcinoma

(2019) Jean-Charles Nault et al.   HEPATOLOGY

Molecular and histological correlations in liver cancer

(2019) Julien Calderaro et al.   JOURNAL OF HEPATOLOGY

Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance

(2018) Marianne Ziol et al.   HEPATOLOGY

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

(2018) Masatoshi Kudo et al.   LANCET

Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

(2018) Ghassan K. Abou-Alfa et al.   NEW ENGLAND JOURNAL OF MEDICINE

Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning

(2018) Nicolas Coudray et al.   NATURE MEDICINE

Molecular therapies and precision medicine for hepatocellular carcinoma

(2018) Josep M. Llovet et al.   Nature Reviews Clinical Oncology

IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade

(2017) Mark Ayers et al.   JOURNAL OF CLINICAL INVESTIGATION

Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification

(2017) Julien Calderaro et al.   JOURNAL OF HEPATOLOGY

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

(2017) Jordi Bruix et al.   LANCET

QuPath: Open source software for digital pathology image analysis

(2017) Peter Bankhead et al.   Scientific Reports

Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features

(2016) Julien Calderaro et al.   HEPATOLOGY

Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

(2015) Stefani Spranger et al.   NATURE

Ward’s Hierarchical Agglomerative Clustering Method: Which Algorithms Implement Ward’s Criterion?

(2014) Fionn Murtagh et al.   JOURNAL OF CLASSIFICATION